nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—EDNRA—uterine cervix—vaginal cancer	0.163	0.163	CbGeAlD
Sulfisoxazole—EDNRA—urethra—vaginal cancer	0.15	0.15	CbGeAlD
Sulfisoxazole—EDNRA—endometrium—vaginal cancer	0.147	0.147	CbGeAlD
Sulfisoxazole—EDNRA—mammalian vulva—vaginal cancer	0.143	0.143	CbGeAlD
Sulfisoxazole—EDNRA—uterus—vaginal cancer	0.136	0.136	CbGeAlD
Sulfisoxazole—EDNRA—female gonad—vaginal cancer	0.111	0.111	CbGeAlD
Sulfisoxazole—EDNRA—vagina—vaginal cancer	0.11	0.11	CbGeAlD
Sulfisoxazole—CYP2C9—female reproductive system—vaginal cancer	0.0404	0.0404	CbGeAlD
